Indian pharmaceutical stocks, including Lupin, Shilpa Medicare, and Natco Pharma, are under scrutiny following recent USFDA inspections at their manufacturing sites. These audits yielded regulatory observations, prompting companies to address the findings. Alkem Laboratories, however, reported no critical issues from a separate Armenian health ministry audit at its Sikkim facility.
Sensex falls 50 points, Nifty above 24,050; Eternal, Sun Pharma, TechM rise 1%
Indian stock markets traded mixed on Monday, with Sensex dipping slightly and Nifty inching higher amidst rising oil prices due to Iran-US tensions. While some
June 29, 2026